← FDA DRUG APPROVALS

FDA NDA · NDA021084

SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS

Sponsor: US ARMY MED RES

APPLICATION
NDA021084
TYPE
NDA
ORIGINAL APPROVAL
2000-02-17
LATEST ACTION
2002-05-06
ROUTE
TOPICAL
DOSAGE FORM
PASTE
MARKETING STATUS
Discontinued

Products

SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTSDiscontinued
PERFLUOROPOLYMETHYLISOPROPYL ETHER 50%, POLYTETRAFLUOROETHYLENE 50% · PASTE · TOPICAL

Approval history

2002-05-06Manufacturing (CMC) · Supplement 1 · priorityAP
2000-02-17Type 1 - New Molecular Entity and Type 4 - New Combination · Original · priority — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →